Altered pathological progression of diaphragm and quadriceps muscle in TNF-deficient, dystrophin-deficient mice (Q46185883)

20 December 2017

title

Altered pathological progression of diaphragm and quadriceps muscle in TNF-deficient, dystrophin-deficient mice (English)

1 reference

20 December 2017

0 references

Spencer MJ

1 reference

20 December 2017

Marino MW

series ordinal

1 reference

20 December 2017

Winckler WM

series ordinal

1 reference

20 December 2017

publication date

1 December 2000

1 reference

20 December 2017

published in

Neuromuscular Disorders

1 reference

20 December 2017

volume

1 reference

20 December 2017

issue

1 reference

20 December 2017

page(s)

612-619

1 reference

20 December 2017

Myonuclear apoptosis in dystrophic mdx muscle occurs by perforin-mediated cytotoxicity

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900160-7

7 January 2021

TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900160-7

7 January 2021

Apoptosis signaling by death receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900160-7

7 January 2021

Is TNF really involved in cachexia?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900160-7

7 January 2021

Cytokine mRNA expression in CSF and peripheral blood mononuclear cells in multiple sclerosis: detection by RT-PCR without in vitro stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900160-7

7 January 2021

Tumor necrosis factor alpha and its receptors in relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900160-7

7 January 2021

Immune activation in myasthenia gravis: soluble interleukin-2 receptor, interferon-gamma and tumor necrosis factor-alpha levels in patients' serum

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900160-7

7 January 2021

Anti-TNF Treatment Reverts Increased Muscle Ubiquitin Gene Expression in Tumour-Bearing Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900160-7

7 January 2021

Characterization of tumor necrosis factor-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900160-7

7 January 2021

Slow-channel transgenic mice: a model of postsynaptic organellar degeneration at the neuromuscular junction.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900160-7

7 January 2021

Cytokines modulate glucose transport in skeletal muscle by inducing the expression of inducible nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900160-7

7 January 2021

The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900160-7

7 January 2021

Differential expression of muscular dystrophy in diaphragm versus hindlimb muscles of mdx mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900160-7

7 January 2021

Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900160-7

7 January 2021

Inhibition of interferon gamma induced interleukin 12 production: a potential mechanism for the anti-inflammatory activities of tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900160-7

7 January 2021

Monoclonal anti‐TNFα Antibody as a Probe of Pathogenesis and Therapy of Rheumatoid Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900160-7

7 January 2021

Attenuation of skeletal muscle ischemia/reperfusion injury by inhibition of tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900160-7

7 January 2021

10.1016/S0960-8966(00)00160-7

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017